Fingerprint
Dive into the research topics of 'N083E (Alliance): long-term outcomes of patients treated in a pilot phase II study of docetaxel, carboplatin, trastuzumab, and lapatinib as adjuvant therapy for early-stage HER2-positive breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically